Despite worries triggered by imbalance of deaths, Shionogi's antibiotic clears FDA panel vote
Concerns over disproportionate mortality had not stopped a panel of experts to recommend that the FDA approve Shionogi’s antibiotic cefiderocol for complicated urinary tract infections …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.